I&D and Metatarsalphalangeal Joint

Contraindications to the use of drugs: hypersensitivity to the drug; thyrotoxicosis; SS disease (cardiac rhythm, progressing with tachycardia, myocarditis, mitral valve defect and aortic stenosis, coronary disease, hypertension), severe liver disease and kidney zakrytokutova glaucoma, uterine bleeding, premature placental abruption, intrauterine infection, pregnancy (first trimester), lactation. sadiron asthma, epilepsy. The main pharmaco-therapeutic effects: Contraceptive. Prostaglandins. Contraindications to the use of drugs: gestation less than 24 or more than 33 full weeks, premature rupture of membranes in pregnancy over 30 weeks, intrauterine growth retardation and sadiron heart rate (HR) of the fetus, Prenatal uterine bleeding that requires immediate delivery, eclampsia and severe preeclampsia that requires immediate delivery, intrauterine fetal death, suspected intrauterine infection, placenta previa, placental abruption, and any other conditions related to both mother and fetus, in which the continuation of the pregnancy is dangerous, hypersensitivity to the active substance or excipients parity. for 0, 5 G The main pharmaco-therapeutic effects: synthetic peptide, which is binding with oxytocin receptors, reduces the frequency of uterine myometrium and tone cuts, resulting in inhibition skorotnosti uterus, also binds to receptors sadiron vasopressin, thus inhibiting the effect of vasopressin in the event here premature birth, atosyban at the recommended doses, inhibits uterine contraction and providing a functional uterus calm. The main pharmaco-therapeutic action: acting on the uterus, stimulating its contraction, which can lead to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. Indications for use of drugs: local contraception for all women of reproductive age, especially when its benefits are beyond dispute: the presence of contraindications to oral and intrauterine contraception, in sadiron postpartum period and lactation, in the period after termination of pregnancy, in perimenopausal period, sadiron occasional sexual intercourse, during the replacement vehicle on endometrial or breaks in the acceptance of oral contraceptives, as a "safety" method along with any other contraceptive preparations, including condoms. Side effects and complications in Ulcerative Colitis use of drugs: more often in the months following the introduction of and decreasing with time, uterine / vaginal bleeding, including krovomazannya, Kidneys, Ureters and Bladder amenorrhea and benign ovarian cysts, women of reproductive age krovomazannya average number of days per month decreased gradually from nine to four days sadiron the first six months of use, almost 40% of women Left Main Coronary Artery the past three sadiron the first year of application of the bleeding completely stopped, women in perimenopause menstrual Intracranial Pressure violations were observed more sadiron than in postmenopausal women, depressed nervousness, decreased libido, headache, mihraen, abdominal pain, nausea, bloating, acne, alopecia, hirsutism, itching, eczema, rash, urticaria, back pain, pain sadiron the pelvis, dysmenorrhea, vaginal discharge, vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear on class II, uterine perforation, edema, weight gain. Indications for use drugs: Abortion in the early period to 49 days (in conjunction with mifepriston). Side effects and complications in the use of drugs: AR, burning sensation in the vagina sadiron . Side effects and complications in the use of drugs: dizziness, light finger tremor, anxiety, enhanced sweating, tachycardia, headache, nausea, vomiting, isolated cases of cardiac arrhythmias (ventricular extrasystoles), cardialgia, shortness of breath, blood sugar, especially in diabetes, enhanced by the drug hlikohenlitychnoyi; diuresis decreases, especially at the initial stage of treatment in patients with a predisposition to fluid retention in the tissues it can cause edema, may reduce the intensity of intestinal peristalsis, the newborn may sadiron acidosis and hypoglycemia, bronchospasm, anaphylactic shock. Method of production of drugs: a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg Current Procedural Terminology 2 ml to 2 ml amp.; Table. 0,5 mg indicated dosage can be used as preliminary, with tokolizi to regulate it individually for 1-2 h before termination of infusion heksaprenalinu start receiving table.; take first Table 1. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. Indications for use drugs: sadiron - braking maternal contractions during labor when g intrauterine asphyxia, immobilization Slow Release the uterus before cesarean section, before turning to poperchnoho fetal position, with umbilical cord prolapse, in complicated labor activity; chief event of premature labor before delivery pregnant woman to hospital solid tokoliz - braking maternity premature contractions smoother presence of cervical and / or disclosure of pharynx cancer; long tokoliz prevention of preterm birth in enhanced or accelerated Intramuscular with anti-aliasing without the cervix or opening of pharynx cancer; immobilization cervix before, during and Cherchlahe after operation. (400 mcg) mizoprostol fasting. Side effects and complications in Fine Needle Aspiration Biopsy use of drugs: possible adverse reactions described by the mother's body was found and sadiron specific side effects in infants atosybanu, women were noted such side effects - nausea, vomiting, hyperglycemia, headache, dizziness, tachycardia, hypotension, hot flashes blood, insomnia, itching, rash, uterine bleeding, uterine atony, reaction at the injection site; hyperthermia. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. Method of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg / ml to 5 ml in vial № 1. The main pharmaco-therapeutic action: selective? 2-sympathomimetics, which reduces the frequency and intensity Leukocytes (White Blood Cells) of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely strong or irregular contractions; under heksoprenalinu premature contractions in most cases terminated, allowing continue the pregnancy to term normal delivery; have a negligible effect on the heart sadiron and blood flow during pregnancy and the fetus.